Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Fungal mycobiome drives IL-33 secretion and type 2 immunity in pancreatic cancer
Aftab Alam, Eric Levanduski, Parker Denz, et al.
Cancer Cell (2022) Vol. 40, Iss. 2, pp. 153-167.e11
Open Access | Times Cited: 217

Showing 1-25 of 217 citing articles:

Pan-cancer analyses reveal cancer-type-specific fungal ecologies and bacteriome interactions
Lian Narunsky-Haziza, Gregory D. Sepich‐Poore, Ilana Livyatan, et al.
Cell (2022) Vol. 185, Iss. 20, pp. 3789-3806.e17
Open Access | Times Cited: 319
A pan-cancer mycobiome analysis reveals fungal involvement in gastrointestinal and lung tumors
Anders B. Dohlman, Jared Klug, Marissa Mesko, et al.
Cell (2022) Vol. 185, Iss. 20, pp. 3807-3822.e12
Open Access | Times Cited: 238
Intratumoral microbiota: roles in cancer initiation, development and therapeutic efficacy
Yang Li, Aitian Li, Ying Wang, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 196
Targeting the gut microbiota for cancer therapy
Miriam R. Fernandes, Poonam Aggarwal, Raquel Costa, et al.
Nature reviews. Cancer (2022) Vol. 22, Iss. 12, pp. 703-722
Closed Access | Times Cited: 149
KRASG12D inhibition reprograms the microenvironment of early and advanced pancreatic cancer to promote FAS-mediated killing by CD8+ T cells
Krishnan K. Mahadevan, Kathleen M. McAndrews, Valerie S. LeBleu, et al.
Cancer Cell (2023) Vol. 41, Iss. 9, pp. 1606-1620.e8
Open Access | Times Cited: 102
Epigenetic plasticity cooperates with cell-cell interactions to direct pancreatic tumorigenesis
Cassandra Burdziak, Direna Alonso‐Curbelo, Thomas Walle, et al.
Science (2023) Vol. 380, Iss. 6645
Open Access | Times Cited: 98
The intratumor mycobiome promotes lung cancer progression via myeloid-derived suppressor cells
Ning‐Ning Liu, Chengxiang Yi, Luqi Wei, et al.
Cancer Cell (2023) Vol. 41, Iss. 11, pp. 1927-1944.e9
Open Access | Times Cited: 82
An IL-4 signalling axis in bone marrow drives pro-tumorigenic myelopoiesis
Nelson M. LaMarche, Samarth Hegde, Matthew D. Park, et al.
Nature (2023) Vol. 625, Iss. 7993, pp. 166-174
Open Access | Times Cited: 82
Intratumoural microbiota: a new frontier in cancer development and therapy
Yaqi Cao, Hui Xia, Xueyun Tan, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 69
Role of the microbiota in response to and recovery from cancer therapy
Stephen J. Blake, Yochai Wolf, Ben Boursi, et al.
Nature reviews. Immunology (2023) Vol. 24, Iss. 5, pp. 308-325
Closed Access | Times Cited: 47
Multi-kingdom gut microbiota analyses define bacterial-fungal interplay and microbial markers of pan-cancer immunotherapy across cohorts
Xiaowen Huang, Muni Hu, Tiantian Sun, et al.
Cell Host & Microbe (2023) Vol. 31, Iss. 11, pp. 1930-1943.e4
Open Access | Times Cited: 44
Current and future immunotherapeutic approaches in pancreatic cancer treatment
Pooya Farhangnia, Hossein Khorramdelazad, Hamid Nickho, et al.
Journal of Hematology & Oncology (2024) Vol. 17, Iss. 1
Open Access | Times Cited: 36
Therapeutic application of human type 2 innate lymphoid cells via induction of granzyme B-mediated tumor cell death
Zhenlong Li, Rui Ma, Hejun Tang, et al.
Cell (2024) Vol. 187, Iss. 3, pp. 624-641.e23
Closed Access | Times Cited: 29
The type 2 cytokine Fc–IL-4 revitalizes exhausted CD8+ T cells against cancer
Bing Feng, Zhiliang Bai, Xiaolei Zhou, et al.
Nature (2024) Vol. 634, Iss. 8034, pp. 712-720
Open Access | Times Cited: 28
Robustness of cancer microbiome signals over a broad range of methodological variation
Gregory D. Sepich‐Poore, Daniel McDonald, Evguenia Kopylova, et al.
Oncogene (2024) Vol. 43, Iss. 15, pp. 1127-1148
Open Access | Times Cited: 24
Roles of microbiota in pancreatic cancer development and treatment
Mariana Santos Cruz, Joseph Tintelnot, Nicola Gagliani
Gut Microbes (2024) Vol. 16, Iss. 1
Open Access | Times Cited: 21
The microbiota–gut–brain axis in Huntington's disease: pathogenic mechanisms and therapeutic targets
Millicent N. Ekwudo, Carolina Gubert, Anthony J. Hannan
FEBS Journal (2024)
Open Access | Times Cited: 21
Broadening oncological boundaries: the intratumoral microbiota
Ying‐Qi Lu, Han Qiao, Xi-Rong Tan, et al.
Trends in Microbiology (2024) Vol. 32, Iss. 8, pp. 807-822
Open Access | Times Cited: 19
Tumor microenvironment as a complex milieu driving cancer progression: a mini review
Zhengrui Li, Jing Li, Xiaolei Bai, et al.
Clinical & Translational Oncology (2024)
Open Access | Times Cited: 19
Breast cancer: pathogenesis and treatments
Xin Xiong, Lewei Zheng, Yu‐Qiang Ding, et al.
Signal Transduction and Targeted Therapy (2025) Vol. 10, Iss. 1
Open Access | Times Cited: 17
The roles of KRAS in cancer metabolism, tumor microenvironment and clinical therapy
Qinglong Ma, Wenyang Zhang, Kongming Wu, et al.
Molecular Cancer (2025) Vol. 24, Iss. 1
Open Access | Times Cited: 6
IL-33-activated ILC2s induce tertiary lymphoid structures in pancreatic cancer
Masataka Amisaki, Abderezak Zebboudj, Hiroshi Yano, et al.
Nature (2025)
Open Access | Times Cited: 5
Fungi, immunosenescence and cancer
Bin Xu, Zan Luo, Xing Niu, et al.
Seminars in Cancer Biology (2025) Vol. 109, pp. 67-82
Closed Access | Times Cited: 4
The mycobiome in human cancer: analytical challenges, molecular mechanisms, and therapeutic implications
Ting Ding, Chang Liu, Zhengyu Li
Molecular Cancer (2025) Vol. 24, Iss. 1
Open Access | Times Cited: 3
Lymph node macrophages drive immune tolerance and resistance to cancer therapy by induction of the immune-regulatory cytokine IL-33
Sara Lamorte, Rene Quevedo, Robbie Jin, et al.
Cancer Cell (2025)
Closed Access | Times Cited: 2
Page 1 - Next Page

Scroll to top